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Improved methods for malaria diagnosis are urgently needed. Here, we evaluate a novel
method named rotating-crystal magneto-optical detection (RMOD) in 956 suspected malaria
patients in Papua New Guinea. RMOD tests can be conducted within minutes and at low cost.
We systematically evaluate the capability of RMOD to detect infections by directly com-
paring it with expert light microscopy, rapid diagnostic tests and polymerase chain reaction
on capillary blood samples. We show that compared to light microscopy, RMOD exhibits
82% sensitivity and 84% specificity to detect any malaria infection and 87% sensitivity and
88% specificity to detect Plasmodium vivax. This indicates that RMOD could be useful in P.
vivax dominated elimination settings. Parasite density correlates well with the quantitative
magneto-optical signal. Importantly, residual hemozoin present in malaria-negative patients
is also detectable by RMOD, indicating its ability to detect previous infections. This could be
exploited to reveal transmission hotspots in low-transmission settings.
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Humans have suffered from malaria for thousands of yearsand still, hundreds of millions of people are infected eachyear. Nowadays, malaria also places a significant social
and economic burden on many tropical developing countries,
further undermining the potential for growth1. Development of
rapid, easy-to-use and low-cost malaria diagnostic methods, with
high sensitivity and specificity, remains an urgent priority in
tropical diseases research2,3. Currently available methods include
the inspection of blood smears using light microscopy (LM),
rapid diagnostic tests (RDTs), and molecular methods, such as
polymerase chain reaction (PCR) or other molecular techniques.
These techniques rely on different diagnostic targets, namely the
direct observation of infected red blood cells (LM), detection of
parasite antigens (RDT), or DNA/RNA (using PCR or other
molecular techniques).
Researchers have also been fascinated by the magnetic prop-
erties of malaria-infected red blood cells (RBCs) for a long time,
since using an inherent and unique physical property such as
malaria parasite-induced RBC magnetism, may enable rapid and
easy diagnosis at low cost. The increased magnetic susceptibility
of RBCs infected with Plasmodium parasites is a striking and
well-described biophysical phenomenon, arising from the meta-
bolism of hemoglobin4–6. Normally, oxygen-bound hemoglobin
is a diamagnetic substance with a magnetic susceptibility close to
that of water7. During infection of RBCs, Plasmodium parasites
break down hemoglobin in their digestive vacuoles and heme
molecules liberated in the process are assembled into iron-
containing organic crystallites called hemozoin2,8–11. These
hemozoin crystals are one of the most distinguishing features of
Plasmodium infection in peripheral blood and played a vital role
in identifying Plasmodium parasites as the cause of malaria and
the mosquito as the agent of transmission in the late 19th
century12,13. During the process of hemozoin formation, hemo-
globin iron is oxidized and concentrated to make up about 10% of
the mass of the newly formed hemozoin crystals, resulting in an
overall paramagnetic behavior of hemozoin4. As such, hemozoin
is an intrinsic biomagnetic marker of infection with Plasmodium.
While the hemozoin crystals are not excreted naturally by the
infected cells until cell rupture, they can easily be made accessible
for diagnostic purposes by lysing blood.
Several approaches to exploit these magnetic properties for
diagnostic purposes have been proposed14–28 and some of these
techniques showed promise under laboratory conditions. How-
ever, only a few magneto-optical (MO) methods have been tested
in operational settings in malaria endemic countries or with
samples collected from malaria-infected patients in endemic
countries. A promising concept for hemozoin-based malaria
diagnosis was described by Newman and colleagues in 200818.
This applicability of the method was demonstrated using syn-
thetic hemozoin (β-hematin) samples, but the ability to detect
infections in a set of LM-confirmed patient samples under
laboratory conditions, was considered requiring further devel-
opment16. Building upon this concept, over recent years, we
developed a novel diagnostic technique, named rotating-crystal
magneto-optical detection (RMOD). As detailed in refs. 23,25,26,
the main conceptual improvements were (i) synchronous mag-
netic rotation of the hemozoin crystals using an array of per-
manent magnets, (ii) application of a circularly polarized
incoming laser beam to maximize the MO signal and to avoid
contributions from components other than hemozoin, and (iii)
highly efficient detection of the MO signal originating from
hemozoin by a balanced photodetection scheme combined with
lock-in filtering. With these improvements, we showed that
RMOD can detect hemozoin in very small concentrations of a few
ppm. Furthermore, we demonstrated that hemozoin can be
detected in lysed blood with very high sensitivity in the low ng/µL
range using RMOD26. Measurements on parasite cultures indi-
cated that RMOD had a limit of detection (LOD) of ∼10 parasites
per µL of blood in samples spiked with P. falciparum26. These
promising results were further supported by studies on P. berghei
and P. yoelii-infected mice23,24. On an operational level, RMOD is
promising as it can be conducted after a short training and
provide test results within minutes. From a funding perspective,
since no expensive reagents are used, the per-sample measure-
ment cost is very low.
The dynamics of hemozoin accumulation and clearance in
natural malaria infections in the human body are more complex
than what can be mimicked in model systems, and intermediate
redistribution and final fate of hemozoin during and following
malaria infections are not well-understood29. Many mechanisms
and intricacies of parasite biology and human response to
infection may collectively determine the actual quantity of
hemozoin in peripheral blood. For example, infected RBCs are
cleared mostly in the liver and spleen, and consequently these
organs become loaded with hemozoin30,31. Leukocytes phagocy-
tose infected RBCs and ingest hemozoin32,33. Late parasite stages
of P. falciparum containing large quantities of hemozoin
sequester in the capillaries34, whereas a higher proportion of late
stages of P. vivax continues to circulate in peripheral blood.
Gametocytes of P. falciparum contain large amounts of hemozoin
and circulate for an extended period of time after an infection has
been cleared or treated35,36. While many aspects of hemozoin
clearance and redistribution in the human body are yet to be
elucidated, there is evidence for long-term persistence of hemo-
zoin in body tissues of people living in endemic areas31,37.
In order to account for these complexities, which are poten-
tially relevant to hemozoin-based malaria diagnosis, we con-
ducted a detailed evaluation of RMOD on almost 1000 suspected
malaria cases in Madang, Papua New Guinea (PNG). PNG has a
complex malaria epidemiology and the study area exhibits high
transmission intensities for both, P. falciparum and P. vivax38.
Using a RMOD prototype device similar to that described in our
previous studies23–26, we systematically compared RMOD per-
formance to conventional diagnostic techniques, namely expert
LM, RDT, and PCR.
Figure 1 provides an overview of the study site and population
(Fig. 1a); a brief comparison of conventional diagnostic techni-
ques together with RMOD (Fig. 1b)4,26,39–42, and a schematic
illustration of the RMOD measurement principle (Fig. 1c–e).
In this study, we establish that magneto-optical hemozoin
detection using RMOD is a promising approach for clinical and
in-field malaria diagnosis, exhibiting a sensitivity and specificity
of 82% and 84%, respectively.
Results
Study population and infection data. A total of 956 suspected
malaria patients were enrolled into the study. All of them had an
RDT result, while 945 had a LM result and a PCR result. The
overall properties of the patient population, and the malaria
diagnostic and parasitological results are given in Table 1.
Overall, based on LM diagnosis 34% of patients were positive
for any malaria infection, as compared to 37% and 34% by RDT
and PCR methods, respectively.
Among the three reference methods used in this study, RDT
was applied at enrollment and expert LM was used as the main
reference method, which is the gold standard recommended by
WHO42.
Comparison of conventional diagnostic methods. When LM
was used as the reference standard for comparison with RDT and
PCR methods, RDT exhibited a sensitivity of 87% and specificity
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of 88%, while PCR showed a sensitivity of 80% and specificity of
89%. A table showing the commonly used measures of agreement
(sensitivity, specificity, predictive values, and Cohen’s κ) is
included as Supplementary Table 1.
For the quantitative methods, LM and PCR, parasite density
and gene copy number correlated well (Spearman Rank
Correlation: P. falciparum R2= 0.79; p < 0.0001; P. vivax: R2=
0.71; p < 0.0001). A correlation plot is shown in Supplementary
Fig. 1.
RMOD results. The median overall magneto-optical signals for
LM positive and LM negative samples were 23.0 mV/V and 1.7
mV/V, respectively. For the RDT positive and negative samples
the median MO signals were 15.1 mV/V and 1.7 mV/V, respec-
tively. For PCR positive and negative samples the median MO
signals were 16.4 mV/V and 1.7 mV/V, respectively. For all three
methods, the differences in the median MO signals for positive
and negative samples were highly statistically significant
(Mann–Whitney test p-values < 0.0001). A detailed summary of
the RMOD results compared to the other methods (LM, RDT,
PCR) is shown in Fig. 2.
We note that the typical error of the RMOD test for a given
sample (based on measurement of three individually prepared
replicates per sample) is two orders of magnitude smaller than
the dynamic range of the methodology defined as the difference
between the median MO signal of the LM negative and LM
positive population. The distribution of the standard deviations
of the MO signals, as determined from measurements of
triplicates, is presented for the whole sample set in Supple-
mentary Fig. 3.
Since RMOD provides a quantitative measurement of
hemozoin content in the blood sample and the detected MO
signals are continuous, receiver operating characteristic (ROC)
analyses were conducted to determine the cut-off MO signals
corresponding to maximum sensitivity and specificity to detect
infection per se, as well as infection with specific parasite
species.
Sensitivity and specificity were determined by selecting the
minimum distance from the ROC curve to the [0,1] coordinate
indicating 100% sensitivity and specificity. The cut-off values and
resulting indicators of agreement between methods are presented
in Table 2. (A list of the predictive values and the area under the
ROC curve is provided in Supplementary Table 2). The ROC
curves are included as Supplementary Fig. 2.
In summary, when based on expert LM as reference standard,
ROC analysis indicated that maximum sensitivity and specificity
of RMOD for the detection of any Plasmodium infection were 82%
and 84%, respectively, and the optimal cut-off value to distinguish
between infections and non-infections was 4.19 mV/V. The overall
agreement between LM and MO was classified as substantial (κ=
0.64)43. Sensitivity and specificity increased for P. vivax infections
(incl. mixed infections) to 87% and 88%, respectively. When based
on PCR as a reference method, overall sensitivity was 78% and
overall specificity was 78%. The overall agreement between PCR
and MO was classified as moderate (κ= 0.54). When RDT was
used as the reference method, sensitivity was 76% and specificity
was 83% with an overall agreement classified as moderate-to-
substantial (κ= 0.58).
Using expert LM as the main reference method, we found that
RMOD detected a higher proportion of P. vivax infections than
the CareStart® RDT (90% vs. 77%) but less P. falciparum
infections (78% vs. 92%).
One has to keep in mind, that none of the methods used for
comparison is a perfect standard, as they are all subject to
systematic and stochastic errors. In fact, we will discuss the data
obtained for a considerable set of patients later, where RMOD
may have detected low-level infections that were not detected by
the other methods.
Fig. 1 Overview of the present study. a Comparison of existing malaria diagnostic techniques to RMOD (b), and working principle of RMOD (c–e).
a Overview of the study population in Madang, Papua New Guinea (base map was created with paintmaps.com). A total of 956 suspected malaria
cases were enrolled of whom 355 were found positive by RDT. Samples from 32 malaria naïve and long-term malaria-free patients were also included.
b Comparison of existing diagnostic techniques with RMOD in terms of their target, approximate testing time26,39–42, level of training39–42,70, limit of
detection26,71–74, and cost per sample39–42,70. * LOD of PCR depends on the volume of blood subjected to the reaction and can be much lower; ** LOD
determined using dilution series of Plasmodium falciparum cultures. c Hemozoin crystals formed by Plasmodium falciparum, as imaged by scanning electron
microscopy. The scanning electron microscopy image was produced by the authors based on the methodology described in Orban et al.26 with slight
modifications. In peripheral blood, hemozoin can be present inside infected red blood cells or phagocytosed in leukocytes. d RMOD principle. Polarization
of the incoming laser beam is tilted due to the linear dichroism of hemozoin crystals. The rotating magnet drives a synchronous rotation of the crystals in
lysed blood, which leads to a periodic tilting of the polarization resulting in a periodic modulation of the intensity of the outgoing laser beam. e The ratio of
the modulated intensity and the mean intensity provides the magneto-optical (MO) signal in mV/V, which is a highly sensitive quantitative measure of
hemozoin concentration and, thus, proportional to the parasite density.
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Parasite density as determined by LM correlated well with the
MO signals as shown in Fig. 3. On average, P. falciparum-infected
samples resulted in lower MO values as compared to P. vivax-
infected samples with similar parasite density. P. falciparum
gametocyte-containing samples formed a characteristic sub-
population that, on average, exhibited higher MO signals at a
similar parasite density when compared with samples containing
only P. falciparum asexual stages. The correlation of MO signals
with parasite density was better for P. vivax (Spearman Rank R=
0.83, p < 0.0001) than for P. falciparum (Spearman Rank R= 0.41,
p < 0.0001).
Despite the clear correlation of MO signal and parasite density
as determined by LM, we observed a considerable scatter of the
MO signal at a given parasite density. This is natural, as the MO
signal depends not only on the density of the parasites but also on
the hemozoin content of the parasites, determined by their
developmental stage. This alone can explain a considerable
variation of the MO signal at any parasite density26,44. However,
we also observed considerable MO signal scatter within the
sample population, which tested negative with all diagnostic
methods used for comparison (RDT, LM, and PCR), and patients
in this group exhibited, on average, higher MO signals than
expected from our previous studies26.
In addition, the median MO signals in the malaria negative
population were statistically significantly higher (more than
double) than those measured in a smaller sample set of malaria
naïve or long-term malaria-free volunteers (n= 32), as shown in
Fig. 4a.
Table 1 Characteristics of the study population and infection
data (n= 956).










Female (%, n) 59.3 (567)
Fever (% with >37.5 °C, n) 16.7 (159)
Anemiab (% with Hb <





Rapid diagnostic test (n= 956) % positive (n)
RDT positive 37.1 (355)
HRP2 6.3 (60)
pLDH 10.3 (98)
HRP2+ pLDH 20.6 (197)
Light Microscopy (n= 945) % positive (n) Parasite density (µL−1,
geometric mean, range)
Any infection 33.7 (318) 4005 (16–111,300)
P. falciparum 20.4 (193) 5957 (16–111,300)
P. vivax 11.0 (104) 1637 (16–36,420)
P. falciparum+ P.vivax 2.1 (20) 9818 (1015–52,349)
P. malariae 0.1 (1) 4800 (–)
P. f. gametocytes 6.7 (63) 276 (16–6520)
P. v. gametocytes 5.9 (56) 168 (32–1349)
PCR (n= 945) % positive (n) 18S rRNA copy numberd
(µL−1, geometric
mean, range)
Any infection 34.3 (324) 3260 (0.5–3.3 × 106)
P. falciparum 20.8 (197) 9196 (4-3.3 × 106)
P. vivax 10.8 (102) 809 (0.5–1.7 × 105)
P. falciparum+ P.vivax 2.6 (25) 2797/316 (2–1.3 × 105/
2–3.5 × 104)
aBold numbers stand for percentages or medians, while numbers in parentheses indicate ranges
or number of patients
bHb/Anemia could only be determined for n= 674 patients
cBased on patient self-reporting
dThe copy number of the 18S rRNA gene target employed in this study is up to 5 per genome.
Fig. 2 RMOD data in comparison to different reference methods. a Expert
LM, (b) PCR and (c) RDT. The panels are divided into box-and-whisker
plots (top) and histograms (bottom). The box-and-whisker plots show
median, interquartile range (IQR), and range of the MO signals for the
respective diagnostic results. The histograms show the raw distribution of
MO signal data (bars) and a smoothened line resulting from applying
generalized additive models of the MO signal frequency distributions for
the respective diagnostic results. All panels share a common horizontal
scale of MO signal. Color and symbol coding for each panel is given by the
font color and the symbols next to the labels of the box-and-whisker plots.
The number of independent biological samples is given as part of each
label. Each biological sample was measured in triplicate.
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Furthermore, within the malaria negative study population,
patients who indicated having had malaria in the last two weeks
exhibited significantly higher MO signals. In summary, this
indicates that previous infection is associated with residual
hemozoin levels, impacting MO diagnosis of acute malaria.
This hypothesis is further substantiated by the observation
that MO signals in the malaria negative (by LM and RDT and
PCR) sub-population were highly correlated with malaria
positivity rate in the overall population (as determined
by LM), when both populations were stratified by age (Fig. 4b,
Spearman Rank R= 0.83; p= 0.003). This implies that either (i)
RMOD detects low-level infections that are not detected by
the other methods or (ii) there is a higher residual hemozoin
level in populations that are more frequently infected with
Plasmodium.
Evidence that the probability for hemozoin to be present in
leukocytes in malaria negative patients is higher for samples with
high MO signals is shown in Fig. 4c. Logistic regression indicated
that for each unit increase in MO signal, the odds for hemozoin-
containing leukocytes to be present in the sample increased by
1.19 (p= 0.007).
Discussion
Improving malaria diagnosis in support of malaria control and
elimination, especially through the development of methods
applicable in resource-limited settings is important and timely45.
Malaria diagnosis is complicated by many factors, including the
frequent occurrence of asymptomatic infections with low parasite
density46.
In this study, we tested a magneto-optical method, namely
RMOD, for automated and rapid measurement of magnetically
induced linear dichroism of hemozoin in close to 1000 human blood
samples from suspected malaria patients in a high-transmission area
of Papua New Guinea (PNG) where both P. falciparum and P. vivax
are common47. In order to evaluate the performance of RMOD, we
conducted a comparison with various conventional diagnostic
methods, namely expert LM, RDT, and PCR.
RMOD may offer advantages over existing methods in terms
of rapidness and cost. While the measurement itself only takes a
few seconds, sample preparation and handling are still in the
order of minutes. As such, a time-to-result of around 10 min is
within reach of the technique. RMOD also has the potential to be
cost-competitive. The cost of a prototype as used in the present
study is similar to that of a standard light microscope and the
cost-per sample is very low as the method is almost reagent-free
(see Fig. 1b).
RMOD quantifies the amount of hemozoin in the sample.
Correspondingly, we observed a strong correlation between the
measured MO signals and parasite density in the peripheral blood
samples. This also led to a substantial agreement of RMOD not
only with LM but also to moderate-to substantial agreement with
RDT and PCR methods43. Hemozoin-containing trophozoite and
schizont stages are known to sequester less frequently in P. vivax
than in P. falciparum infections, resulting in a higher proportion of
these stages present in peripheral blood during P. vivax
infection48,49. Consequently, we observed approximately 10-fold
higher average MO signals for P. vivax as compared to P. falci-
parum (asexual stages only) at similar parasite densities (compare,
e.g., Figs. 2a and 3a). Similarly, for samples containing P. falci-
parum gametocytes, average MO signals were found to be sig-
nificantly higher in the statistical analyses than for samples
Table 2 Cut-off values, and estimated sensitivity and
specificity of RMOD resulting from ROC analysis performed










all LM positive 4.19 82 (78–86) 84 (81–86) 0.64
P. falciparum 4.00 79 (73–84) 83 (80–86) 0.57
P. vivax 5.15 87 (80–92) 88 (85–90) 0.63
P.f+ P.v.
(mixed)




3.54 78 (73–82) 78 (75–81) 0.54
P. falciparum 3.01 80 (74–85) 75 (71–78) 0.47
P. vivax 4.84 79 (71–86) 84 (81–87) 0.51
P.f.+P.v.
(mixed)




4.11 76 (71–80) 83 (79–86) 0.58
PfHRP2 2.58 65 (52–77) 70 (66–73) 0.16
pLDH 5.14 81 (71–88) 87 (84–90) 0.55
PfHRP2
+pLDH
4.11 81 (75–86) 83 (79–86) 0.57
aBold numbers are the means and numbers in parentheses are the 95% confidence intervals
bκ is the coefficient of agreement according to Landis and Koch43.
Fig. 3 Correlation of MO signals with parasite density as determined by
expert LM. a MO signals as a function of parasite density for different
species, as determined by expert LM. P. falciparum mono-infections without
gametocytes are represented by red circles, P. vivax mono-infections by
blue diamonds and P.f. + P.v. mixed infections by green triangles. Samples
with gametocytes in P. falciparum mono-infections (P.f. + gam.) are
represented by orange squares. The larger, solid-colored symbols show
median MO signals and median parasite densities for representative
parasite density ranges, with 95% CIs as error bars. The smaller,
transparent symbols show the individual test results. The number of
biologically independent samples examined over three independent MO
experiments is indicated in parentheses. The typical error of the MO signal
for a given sample (measured in triplicates) is 11% (individual error bars are
not indicated). The diagonal dashed line with a slope equal to 1 represents
linear proportionality of the MO signal with parasite density. The dashed
horizontal black line represents the cut-off value (MO= 4.19mV/V)
determined by the ROC analysis for all LM positive samples (see Table 2).
The dashed horizontal gray line is the median MO background signal (0.47
mV/V) determined in malaria naïve volunteers, which provides a
significantly lower cut-off value. b MO signals of patient samples with
undetectable parasites by expert LM (n= 627). Also indicated are the
median, 1.67 (95% CI: 1.57–1.78), and the IQR (1.06–2.89) of the MO
signals.
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containing P. falciparum asexual stages only. This is due to the
high per-cell hemozoin content found in P. falciparum
gametocytes14,22,35. As a result, RMOD sensitivity and specificity to
detect P. vivax and mixed infections were significantly higher than
that observed for P. falciparum when compared to expert LM and
PCR. When RDT was used as a reference method, sensitivity and
specificity were observed to be higher in pLDH positive samples as
these more frequently identify P. vivax infections (see Table 2).
As such, our data hint towards RMOD working ‘better’ for P.
vivax. However, the current results at the same time indicate that
RMOD also has a real potential to diagnose P. falciparum
infections. This is likely due to a combination of reasons: (i)
presence (although infrequent) of late P.f. stages in peripheral
blood50; (ii) presence of P.f. gametocytes; (iii) the presence of ‘free
hemozoin’ released by rupture of sequestered parasites and (iv)
the fact that some hemozoin is produced at the ring stage. Our
very recent RMOD study, quantifying the hemozoin production
during the life cycle of P. falciparum parasites shows that ~20% of
the hemozoin is produced during ring-stage development44.
While MO signals were significantly correlated with parasite
density, the scatter of MO signals in the malaria negative popu-
lation (compare Figs. 3b, 4a) led to considerably higher cut-off
levels, below which a measurement is considered negative, than
the background MO signal level observed with malaria naïve
volunteer samples25,26. This led to a seemingly decreased diag-
nostic performance. The most plausible hypothesis to explain this
observation is that a considerable proportion of the patients had
hemozoin in their peripheral blood at levels still detectable by
RMOD, yet in the absence of an infection detectable by any of the
methods used for comparison.
Low-density, asymptomatic infections that are undetectable to
expert LM, conventional PCR, and RDTs are highly prevalent in
the study area46. Such low-level, undetectable infections may still
lead to the accumulation of hemozoin in peripheral blood. In
addition, hemozoin persists, in the peripheral circulation, usually
inside leukocytes51. Hemozoin-containing leukocytes can circu-
late for extended periods after clearance of acute infections51,52,
which may account, in part, for the high-level background MO
signal we observed in the apparently malaria negative population.
P. falciparum gametocytes, which, in comparison to asexual
stages, contain large amounts of hemozoin, exhibit delayed
Fig. 4 Analysis of MO signals in the patient population found malaria
negative by the reference methods. a Comparison of MO signals between
malaria negative (by LM, PCR and RDT) study participants who reported a
recent malaria infection in the two weeks preceding the measurement (n=
219) and those who did not report a recent infection (n= 294). The graph
also shows measurements from n= 12 long-term malaria-free volunteers
measured during this study, as well as previous data from n= 20 malaria
naïve volunteers measured in non-endemic settings using the same
protocol. All RMOD measurements were done in triplicate. The
distributions were compared using two-sided Mann-Whitney tests
resulting in the p-values indicated in the graph. The box-and-whisker plots
show the median, the IQR, the 1–99 percentile of the MO signals and
the individual data points which fall outside the 1–99 percentile range.
b Correlation between LM-based infection positivity rate and MO signals in
patients with undetectable malaria in corresponding age groups. LM
positivity rate (blue squares) is shown with the error band representing the
95% confidence intervals (CIs) of proportions. MO signals (black circles)
are shown as medians per age group with error bars representing 95% CIs
of the medians. The dashed black line corresponds to the median
background MO signal in the malaria naïve volunteer population. (0.47
mV/V). The x-axis denotes age groups and the number of biologically
independent samples (in parentheses, measured in triplicates) per group
for MO measurements (nMO, black) and expert LM (nLM, blue).
c Probability of hemozoin-containing leukocyte presence (PHz+) versus MO
signal in malaria negative samples. The black line and gray-shaded area are
the probability prediction and 95% confidence band of the logistic
regression model. The red circles are the binary data for hemozoin-
containing leukocyte presence (1) or absence (0).
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clearance after antimalarial treatment and may be in circulation
for long periods of time, often in very low numbers that are
difficult to detect14,22,53. Hemozoin is also known to persist in the
liver and spleen of previously infected individuals for extended
periods of time54,55. On this basis, it is likely that in high trans-
mission settings, such as the setting of the present study, elevated
hemozoin levels are maintained in the peripheral blood of a large
proportion of the general population, either from concurrent low-
level infections that are otherwise undetectable56, or from pre-
vious infections.
First-hand evidence supporting this hypothesis, is shown in
Fig. 4. Patients indicating a malaria infection within the previous
two weeks exhibited significantly higher MO signals. In addition,
samples from n= 32 long-term malaria-free or malaria-naïve
volunteers exhibited much lower MO signals. When malaria
negative patients, who had indicated a recent malaria infection,
were excluded from the ROC analyses, overall sensitivity and
specificity in comparison to expert LM increased to 86% and 84%,
respectively.
It is likely that in low-transmission and/or elimination settings,
which many countries are currently working towards, the residual
hemozoin level in the population will be lower, and the back-
ground MO signal should approach that measured for long-term
malaria-free and malaria-naïve volunteer samples. This would
lead to an increase in the ability of RMOD to discriminate
infections in these settings. In order to estimate the magnitude of
improvement, to be expected when lowering the MO signal
threshold to the level observed in long-term malaria-free and
malaria naïve-individuals, we used the distribution of MO signals
obtained from these samples (n= 32) together with the dis-
tribution of MO signals from samples that were positive for P.
vivax by expert LM in the present study (n= 124) in a ROC
analysis. This resulted in an expected sensitivity of 97% and
specificity of 97%, together with a near perfect agreement between
LM and RMOD techniques, with κ= 0.91. Furthermore, an
analogous calculation for the P. falciparum samples (n= 213)
also resulted in 97% sensitivity and 97% specificity with κ= 0.87.
In conclusion, we present an extensive assessment of a pro-
mising novel method to diagnose malaria rapidly and at low cost
in a high transmission setting and a population of symptomatic,
suspected malaria cases in PNG. The present study shows that in
such a setting, the RMOD performs well in comparison to expert
LM-based diagnosis, the most reliable reference method in our
study. However, residual hemozoin levels presented a significant
limitation, compromising the ability of RMOD to discriminate
between current and previous infections. This limitation is
expected to be reduced in low-transmission settings.
In the current state of development, RMOD cannot distin-
guish between parasite species in P. falciparum and P. vivax co-
endemic settings. Further development of RMOD is ongoing to
address species-specific diagnosis, by taking advantage of the
species-specific shape and size distributions of hemozoin crys-
tals57. It should be noted, that RDTs also cannot clearly dis-
tinguish parasite species. For example, the RDT used in this
study cannot distinguish mixed species infections58, and was
able to detect P. vivax (based on the pLDH-line test result) with
60% sensitivity and 97% specificity.
While the results of the present study illustrate the potential of
RMOD and hemozoin-based malaria diagnosis, they also pose
new questions. Future studies are required to further investigate
how residual hemozoin levels in different transmission intensity
settings, and longitudinal hemozoin dynamics in infected and
treated individuals influence RMOD measurement outcomes. It is
especially worthwhile considering and further exploring the
usefulness of RMOD-based hemozoin detection for malaria
diagnosis and in epidemiological studies in low-transmission and
elimination settings. The PCR method employed in this study did
not achieve an optimal LOD and should thus not be considered as
a molecular gold standard. Future studies should include high-
volume, ultrasensitive molecular techniques59,60 to detect ultra-
low density infections and relate their presence to RMOD mea-
surement outcomes.
The current prototype device was deliberately kept flexible so
that measurement parameters could be adjusted and optimized.
This makes the operation more complex than what we would
envision for a finalized diagnostic product, which would focus on
ease of use, standardization, and high throughput. For such a final
product, we would envision the operation to be very simple at the
‘push of a button’, without requiring any compromise on the
present diagnostic performance, which is similar to that of LM.
Many countries in low-transmission or elimination settings
experience an increase in the proportion of P. vivax infections
and it can be expected that P. vivax will represent the vast
majority of infections in the malaria end-game outside of
Africa61. Given the rapid and low-cost measurement possible
with RMOD and the promising results in particular for P. vivax,
the method may play a beneficial role in such settings. Since
hemozoin is an intrinsic biomarker of Plasmodium spp. infection
that persists in peripheral blood (similar to the targets of, e.g.,
serological antibody tests) it may be worth investigating in how
far RMOD can be used as a tool to detect transmission hotspots
in elimination settings.
Methods
Study site and sample collection. Madang is located on the north coast of Papua
New Guinea (Fig. 1a). P. falciparum and P. vivax are highly endemic, and P.
malaria and P. ovale are also present in the study area38. Capillary blood samples
were collected by qualified nurses or community health workers at Yagaum Rural
Hospital located outside of Madang and at Madang Town Clinic in 2017–2019.
Blood samples originated from suspected malaria cases presenting as
outpatients at the respective clinics. An RDT (CareStart® Malaria, Accessbio Inc.,
USA) and two blood slides for LM were prepared at enrollment. All RDT positive
patients received standard antimalarial treatment according to PNG malaria
treatment guidelines. This study received ethical clearance by the PNG Institute of
Medical Research (PNGIMR) Institutional Review Board and the PNG Medical
Research Advisory Committee (MRAC, #16.45).
Samples from n= 12 long-term malaria-free and n= 20 malaria-naïve
volunteers were also measured using RMOD and included in the analysis of the
present study.
All tests were carried out independently and blinded to the results of each other.
Written informed consent was provided by all study participants and, in case of
minor patients, from their parents or guardians, in addition to assent from the
minor patients.
Light microscopy. LM was conducted by the PNGIMR microscopy unit consisting
of experienced, WHO-certified microscopists. Slides were read, and parasite den-
sity determined according to standard WHO guidelines for malaria LM using thick
blood smears for parasite density quantification62. Blood smears were examined
independently by two skilled microscopists, for 200 thick-film fields (×1000
magnification) before being declared Plasmodium-negative. Parasite density was
calculated from the number of parasites per 200–500 leukocytes (depending on
parasite density) and an assumed leukocyte density of 8000 μL−1 63. Slides dis-
crepant for positivity/negativity, species determination, or density (>2 log differ-
ence) were adjudicated by a WHO-certified level 1 (expert) microscopist. Slides
were scored as LM positive for an individual Plasmodium species if the species was
detected independently by at least two microscopists. Densities were calculated as
the geometric mean densities of all positive reads47.
DNA extraction and real-time PCR. DNA extraction was performed on 200 µL of
whole blood using DNA extraction kits for 96 well plates (Favorgen Biotech Corp,
Taiwan). DNA was eluted in 30 µL of RNAse/DNAse free water. The present study
employed a two-step PCR protocol as described previously using molecular probes
targeting Plasmodium 18S rRNA genes. Briefly, a screening PCR to exclude
negative samples was first run on all samples64. Samples that were positive by the
screening PCR were then subjected to a species-specific quantitative real-time PCR
(qPCR) as described elsewhere using a CFX96 Touch qPCR system (Bio-Rad
Laboratories Pty., Ltd., Australia)65. Therefore, it was possible to quantify parasite
density based on gene copy number. For all reactions, 4 µL of the DNA eluate was
used, corresponding to DNA material from roughly 26.7 µL of the original blood
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sample. Primer sequences and thermocycling conditions are provided in Supple-
mentary Information Tables 3 and 4, respectively.
Rotating magneto-optical detection (RMOD) measurements. The concept of
the rotating-crystal magneto-optical setup and the underlying physical principles of
hemozoin detection are described in detail in our former studies24–26. The working
principle is depicted in Fig. 1d. In combination with their magnetism, the elon-
gated, rod or brick-shaped hemozoin crystals exhibit anisotropic optical properties,
in particular, magnetically induced linear dichroism57. Here, we refer to this effect
as the magneto-optical (MO) signal, which is the marker-signal for hemozoin
detection and quantification18,25.
For the preparation of the blood lysates, 35 µL of whole blood was mixed with
315 µL of lysis solution (13.3 mM of NaOH and 0.03% v/v of Triton X-100 in
distilled water) and allowed to stand for at least 10 min to ensure complete lysis.
Thereafter, 280 µL of the lysate was transferred into the optical sample holders and
measurements were performed without further delay. Samples for RMOD
measurements were prepared in triplicate per blood sample.
The hemolysed blood sample, transferred into a cylindrical sample holder, is
inserted into the center of a ring-shaped assembly of permanent magnets, which
creates a strong uniform magnetic field (B ~ 1 T) at the sample position. This
magnetic field induces the co-alignment of the hemozoin crystals, and when the
magnetic ring is rotated, the co-aligned hemozoin crystals follow this rotation.
During the measurement, polarized light from a laser diode is transmitted through
the sample in the direction perpendicular to the plane of rotation of the magnetic
field. The rotation of the co-aligned dichroic crystals gives rise to a periodic change
in the detected intensity. The modulated intensity, divided by the average intensity,
corresponds to the measured ‘MO signal’, which is displayed in the corresponding
figures in mV/V units24.
In general, optical samples were prepared and measured immediately after
collection and transport to the laboratory (n= 943), but n= 22 samples were
frozen overnight before preparation and MO measurement due to logistical
constraints. The measurement of a single sample took approximately 3–5 min
(Fig. 1b).
Data analysis. Data were entered into an electronic data capture system (Epi-
collect 5, Imperial College) using standardized data collection forms and into
Microsoft Excel 2016 (Microsoft Corporation) spreadsheets. Data analysis and
graphing were conducted using Microsoft Excel 2016 (Microsoft Corporation),
Graphpad Prism 8.0 (Graph Pad Software), and Stata 13 (StataCorp). No custo-
mized computer codes were used.
Proportions are presented alongside their exact 95% confidence intervals66.
Continuous data are presented as averages (95% confidence intervals) for normally
distributed data and medians with interquartile range or range for not normally
distributed data.
LM, PCR, and RDT results were used to compare against RMOD results.
Following the recommendation of WHO, LM was used as the main reference
method. Methods were compared by calculating the sensitivity and specificity,
predictive values, and agreement (κ) with respect to the reference method67.
Receiver operating characteristic (ROC) analyses were used to determine the cut-
offs for the continuous RMOD data to best predict presence or absence of infection,
i.e., to determine sensitivity and specificity by calculating the minimum distance
between the ROC curve and the [0,1] coordinate indicating 100% sensitivity and
100% specificity68.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data collected in this study and source data for all tables and figures are provided with
this paper as a source data file and also under 10.6084/m9.figshare.13078181.v1 (ref. 69).
All relevant data are also available from the authors. Source data are provided with
this paper.
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